| |
|
2026 |
|
2025 |
| |
|
£ |
£ |
|
£ |
£ |
| Fixed assets |
|
|
7,420 |
|
|
9,231 |
| Current assets |
|
174,911 |
|
|
169,001 |
|
| Prepayments and accrued income |
|
0 |
|
|
7,280 |
|
| Creditors: amount falling due within one year |
|
(21,971) |
|
|
(15,417) |
|
|
Net current assets
|
|
|
152,940
|
|
|
160,864
|
|
Total assets less current liabilities
|
|
|
160,360 |
|
|
170,095 |
| Provisions for liabilities |
|
|
0 |
|
|
(275) |
| Accruals and deferred income |
|
|
(49,975) |
|
|
(26,110) |
|
Net assets
|
|
|
110,385 |
|
|
143,710 |
| |
|
|
|
|
|
|
|
Capital and reserves
|
|
|
110,385 |
|
|
143,710 |
| |
NOTES TO THE ACCOUNTS
General Information
BIOPHARM TECHNICAL SOLUTIONS LIMITED is a private company, limited by shares, registered in England and Wales, registration number 04023142, registration address 12 Masefield Crescent, Abingdon, Oxfordshire, OX14 5PH.
The presentation currency is £ sterling.
| 1. |
Accounting policies
Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
|
| 2. |
Average number of employees Average number of employees during the period was 4 (2025 : 4). |
For the year ended 30 June 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 27 October 2026 and were signed on its behalf by: --------------------------------
Paula Smith
Director |
2
|